SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-002299
Filing Date
2024-07-30
Accepted
2024-07-30 09:00:09
Documents
15
Period of Report
2024-07-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210237-8k_incannex.htm   iXBRL 8-K 36117
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED JULY 30, 2024 ea021023701ex99-1_incannex.htm EX-99.1 30089
3 GRAPHIC ex99-1_001.jpg GRAPHIC 11639
  Complete submission text file 0001013762-24-002299.txt   264913

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE incannexcomau-20240730.xsd EX-101.SCH 3051
5 XBRL LABEL FILE incannexcomau-20240730_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE incannexcomau-20240730_pre.xml EX-101.PRE 22374
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0210237-8k_incannex_htm.xml XML 3795
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 241154660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)